Alembic Pharmaceuticals Ltd Half Yearly Results

Gross Sales

3,462.37

3,209.71

3,147.55

3,081.08

2,915.47

Excise Duty

0

0

0

0

0

Net Sales

3,462.37

3,209.71

3,147.55

3,081.08

2,915.47

Other Operating Income

0

0

0

0

0

Other Income

23.4

32.9

6.49

21.82

1.33

Total Income

3,485.77

3,242.61

3,154.04

3,102.9

2,916.8

Total Expenditure

2,930.23

2,733.62

2,621.57

2,674.68

2,485.41

PBIDT

555.54

508.99

532.47

428.22

431.39

Interest

46.78

31.99

26.11

30.08

28.97

PBDT

508.76

477

506.36

398.14

402.42

Depreciation

139.03

139.55

138.93

133.74

140.63

Minority Interest Before NP

0

0

0

0

0

Tax

43.13

79.05

54.22

7.84

-21.73

Deferred Tax

32.28

-29.29

-45.45

-0.6

17.87

Reported Profit After Tax

294.32

287.69

358.66

257.16

265.65

Minority Interest After NP

-0.98

-0.43

0

0

0

Net Profit after Minority Interest

295.3

288.12

358.66

257.16

274.52

Extra-ordinary Items

0.01

9.86

0

0

0

Adjusted Profit After Extra-ordinary item

295.29

278.26

358.66

257.16

274.52

EPS (Unit Curr.)

15.02

14.64

18.25

13.08

13.97

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

39.31

39.31

39.31

39.31

39.31

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

16.04

15.85

16.91

13.89

14.79

PBDTM(%)

-

-

-

-

-

PATM(%)

8.5

8.96

11.39

8.34

9.11